as 11-15-2024 4:00pm EST
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | DALLAS |
Market Cap: | 397.2M | IPO Year: | N/A |
Target Price: | $9.15 | AVG Volume (30 days): | 402.1K |
Analyst Decision: | Hold | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.33 | EPS Growth: | N/A |
52 Week Low/High: | $6.85 - $11.74 | Next Earning Date: | 11-06-2024 |
Revenue: | $1,037,200,000 | Revenue Growth: | -1.11% |
Revenue Growth (this year): | 2.55% | Revenue Growth (next year): | 3.63% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bolton Jeffrey | EHAB | Director | Aug 22 '24 | Buy | $8.01 | 5,000 | $40,050.00 | 78,877 |
EHAB Breaking Stock News: Dive into EHAB Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Insider Monkey
9 days ago
Simply Wall St.
9 days ago
GuruFocus.com
9 days ago
Thomson Reuters StreetEvents
9 days ago
Business Wire
10 days ago
Zacks
11 days ago
Associated Press Finance
11 days ago
The information presented on this page, "EHAB Enhabit Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.